News$3.6 Million NIH Grant Awarded to NYBC Scientist for Research on River Blindness Vaccineby New York Blood CenterGrant brings NYBC scientists one step closer to developing a preventive vaccine ready for first-in-human trials by 2020
NewsScientist Makes Groundbreaking Discoveries on the Parasite That Causes River Blindness Diseaseby New York Blood CenterTwo new studies provide an unprecedented look into the genome, transcriptome, and proteome of the river blindness parasite and its bacterial endosymbiont, Wolbachia
NewsNYBC Scientists Partner In New Discovery for Development of MERS Vaccinesby New York Blood CenterMERS, a severe respiratory illness with symptoms of fever, cough and shortness of breath, has a mortality rate of approximately 36 percent